📚 L3 Free Living Amaoebae

📚 Lecture Overview

Osteoarthritis (OA) is a progressive, complex, multifactorial disorder affecting the whole joint, characterized primarily by hyaline cartilage degeneration, subchondral bone remodeling, and secondary synovial inflammation. As the most prevalent joint disease and a primary cause of chronic disability in older adults, understanding its pathogenesis, clinical presentation, and management is essential for clinical practice and board examinations.

🎯 Key Concepts & Definitions

• Osteoarthritis (OA): A progressive degenerative disorder of synovial joints involving articular cartilage, subchondral bone, synovium, ligaments, and capsule.
• Heberden's Nodes: Hard bony enlargements located at the distal interphalangeal (DIP) joints of the hands.
• Bouchard's Nodes: Hard bony enlargements located at the proximal interphalangeal (PIP) joints of the hands.
• Erosive Osteoarthritis: An aggressive, generalized form of hand OA affecting DIP and PIP joints in middle-aged women, characterized by central subchondral erosions ("seagull" appearance).
• Subchondral Sclerosis: Increased bone density (thickening) beneath the degenerated cartilage visible on X-ray.
• Osteophytes: Bone spurs formed at the joint margins as a hypertrophic repair response to joint stress.
• DAMPs (Damage-Associated Molecular Patterns): Extracellular matrix breakdown products and alarmins released upon tissue injury that trigger synovial inflammation via pattern recognition receptors.
• Gel Phenomenon / Morning Stiffness: Brief joint stiffness occurring after inactivity, characteristically lasting less than 10 minutes in OA.

📖 Main Content

1. Classification & Risk Factors

Classification

1. Primary (Idiopathic) Osteoarthritis:
   - Localized: Specific joints such as hand (nodal/non-nodal), foot (1st MTP), hip, knee, spine (spondylosis), or single sites (glenohumeral, TMJ, SI joint).
   - Generalized: Involves 3 or more joint groups (peripheral, central, or spinal).
   - Erosive OA: Aggressive variant affecting PIP/DIP joints in middle-aged women causing digit deformities.
2. Secondary Osteoarthritis:
   - Developmental/Anatomic: Congenital hip dislocation, Legg-Calvé-Perthes disease, slipped capital femoral epiphysis, leg length discrepancy, varus/valgus malalignment.
   - Trauma: Intra-articular fractures, meniscectomy, long-term occupational wear.
   - Metabolic/Endocrine: Hemochromatosis, ochronosis, Gaucher disease, acromegaly, diabetes mellitus, hypothyroidism, hyperparathyroidism.
   - Calcium Deposition: Calcium pyrophosphate deposition disease (CPPD), apatite arthropathy.
   - Neuropathic: Charcot joints (e.g., secondary to diabetes or tabes dorsalis).

Risk Factors

• Age: Strongest independent risk factor.
• Gender: Female-to-male ratio is approximately 2:1.
• Obesity: Increases mechanical load on knees/hips and raises risk in non-weight-bearing hand joints via systemic inflammatory adipokines.
• Genetics: Mutations in genes encoding extracellular matrix (ECM) structural proteins.
• Mechanical Factors: Joint trauma, malalignment, and heavy occupational load.

2. Pathogenesis & Pathology

OA results from an imbalance in cartilage matrix turnover where degradation exceeds synthesis.

Subchondral Bone & Cartilage Damage
               │
               ▼
  Release of ECM Breakdown Products & DAMPs
               │
               ▼
  Activation of Synovial Macrophages & Chondrocytes
               │
               ▼
  Production of Inflammatory Mediators (Cytokines)
               │
               ▼
  Induction of Proteolytic Enzymes (MMPs, ADAMTS)
               │
               ▼
  Accelerated Matrix Degradation (Vicious Cycle)

Pathological Findings

• Cartilage: Fibrillation, erosion, and thinning leading to joint space narrowing.
• Subchondral Bone: Sclerosis (bone thickening), subchondral pseudocysts with sclerotic walls, and peripheral osteophytes.
• Synovium: Secondary low-grade synovitis and capsular thickening/hyperplasia.
• Vascularity: Neoangiogenesis penetrating from subchondral bone into normally avascular cartilage.

3. Joint-Specific Clinical Manifestations

4. Diagnostic Evaluation

Clinical Features

• Pain Pattern: Mechanical pain exacerbated by activity/weight-bearing and relieved by rest.
• Stiffness: Morning stiffness or post-rest gel phenomenon lasting < 10 minutes.
• Physical Signs: Bony enlargement, joint line tenderness, crepitus on motion, restricted ROM, muscle atrophy (e.g., quadriceps).

Laboratory Findings

• Blood Tests: Typically normal (acute phase reactants normal; ANA and RF negative unless coexisting autoimmune disease is present).
• Synovial Fluid Analysis: Non-inflammatory profile:
• Appearance: Clear, yellow, viscous.
• WBC Count: < 2,000 cells/mm³.
• Neutrophils: < 25% PMNs.

Imaging (X-Ray Findings)

Classic cardinal radiographic features of OA:
1. Asymmetric joint space narrowing
2. Subchondral sclerosis
3. Osteophyte formation at joint margins
4. Subchondral cysts (pseudocysts)

5. Treatment Management Algorithm

Non-Pharmacologic (First-Line for All Patients)

• Patient education and self-management support.
• Exercise: Aerobic and quadriceps/muscle-strengthening programs.
• Weight loss (crucial for weight-bearing joint OA).
• Physical therapy, orthotics, and assistive walking devices.

Pharmacologic Therapy

• Topical Analgesics: Topical NSAIDs (first-line for knee/hand), Capsaicin, Methylsalicylate.
• Oral Analgesics: Acetaminophen (paracetamol), Non-selective or COX-2 selective NSAIDs (use lowest effective dose), Tramadol/Opioids for refractory pain.
• Intra-articular Injections:
• Glucocorticoids: Provides rapid short-term pain relief during acute flares.
• Hyaluronic Acid / Platelet-Rich Plasma (PRP): Local symptom control.
• Rationale for local injection: High local bioavailability without systemic toxicity, overcoming the poor penetration of oral drugs into avascular cartilage.

Surgical Therapy

• Total Joint Replacement (Arthroplasty): Indicated for severe, refractory pain causing significant functional disability and loss of quality of life despite maximal conservative management.
• Note: Referral should not be denied based solely on age, sex, BMI, smoking status, or comorbidities.

📊 Visual Learning

Diagram 1: OA Pathogenesis Flowchart

Diagram 2: Hand Joint Involvement Mindmap

Diagram 3: Stepwise Osteoarthritis Management Graph

💡 Important Points to Remember

• OA is primarily a degenerative whole-joint disorder with secondary inflammatory components, not a primary systemic inflammatory disease.
• Heberden's nodes occur at DIP joints; Bouchard's nodes occur at PIP joints.
• Metacarpophalangeal (MCP) joints are rarely affected in primary OA; MCP involvement strongly suggests secondary causes like CPPD, hemochromatosis, or rheumatoid arthritis.
• Hip OA pain frequently radiates to the groin/thigh and may present exclusively as knee pain (referred pain via the obturator/femoral nerves).
• Morning stiffness in OA lasts < 10 minutes (rarely > 30 minutes), distinguishing it from Rheumatoid Arthritis (> 1 hour).
• Synovial fluid in OA is non-inflammatory with WBC < 2,000/mm³ and PMN < 25%.
• Obesity increases the risk of OA in hands as well as knees, demonstrating that systemic metabolic/inflammatory factors (adipokines) play a key role alongside mechanical stress.
• The 4 cardinal X-ray signs of OA are: Joint space narrowing, Osteophytes, Subchondral sclerosis, and Subchondral cysts.
• Femoropatellar OA causes pain during stair climbing or descending, whereas femorotibial OA causes pain during flat ground walking.
• Intra-articular route delivers drugs directly into avascular cartilage while avoiding systemic toxicities.

⚠️ Common Exam Questions & Traps

Exam Traps & Tricks

1. The MCP Joint Trap:
   - Examiner Trick: "A 60-year-old patient presents with pain and bony swelling in the 2nd and 3rd MCP joints. What is the diagnosis?"
   - Trap: Choosing primary hand osteoarthritis.
   - Fact: Primary OA spares the MCP joints. MCP joint osteoarthropathy indicates secondary conditions such as hemochromatosis or CPPD (pseudogout).

2. Referred Hip Pain Trick:
   - Examiner Trick: A patient complains solely of persistent medial knee pain, but knee X-rays and exam are unremarkable.
   - Trap: Ordering advanced knee imaging instead of examining the hip.
   - Fact: Hip OA often presents strictly as knee pain. Always perform passive internal rotation of the hip.

3. Morning Stiffness Duration:
   - Examiner Trick: Matching joint diseases with clinical features.
   - Trap: Selecting OA for a patient with 2 hours of morning stiffness.
   - Fact: OA morning stiffness lasts < 10–30 minutes. Stiffness lasting > 1 hour points to inflammatory arthropathies like RA.

4. Synovial Fluid Analysis MCQs:
   - Examiner Trick: Providing a synovial fluid WBC count of 1,200 cells/mm³ and asking if it indicates septic arthritis or rheumatoid arthritis.
   - Fact: WBC < 2,000 cells/mm³ represents non-inflammatory fluid diagnostic of OA or mechanical derangement.

5. Exclusion Criteria for Joint Replacement Referral:
   - Examiner Trick: "Which of the following is an absolute contraindication for joint replacement referral: Obesity (BMI > 35), Age > 80, or Smoking?"
   - Fact: None of these. Modern guidelines state patients should not be excluded from referral based on age, gender, smoking, or obesity alone.

📝 Quick Review Checklist

I can differentiate between Heberden's and Bouchard's nodes by their anatomical location.
I can list the four cardinal radiographic features of osteoarthritis seen on X-ray.
I know the normal cutoff values for synovial fluid WBC and PMN percentage in OA.
I understand why MCP joint involvement suggests secondary rather than primary OA.
I can explain why obesity increases the risk of hand osteoarthritis.
I can distinguish femoropatellar pain triggers (stairs) from femorotibial pain triggers (flat walking).
I know the criteria for referring an OA patient for joint replacement surgery.
I can identify the characteristic "seagull erosion" pattern seen in erosive osteoarthritis.